Open AccessMedicine
B. Fisher, J. Costantino, D. Wickerham, C. Redmond, M. Kavanah, W. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-chiu, L. Ford, N. Wolmark
tlooto Summary
Tamoxifen decreases the incidence of invasive and noninvasive breast cancer and its use as a breast cancer preventive agent is appropriate in many women at increased risk for the disease.
Abstract
Abstract is not available.
Citation format
FISHER, B., et al. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project p-1 study. JNCI-Journal of the National Cancer Institute, 1999, 90 18: 1371–88.